Mutations in the NKX2-5 gene in patients with stroke and patent foramen ovale

Clinical Neurology and Neurosurgery

Volumn 111, Issue 7, 2009, Pages 574-578

  Belvís, Robert ^a   Tizzano, Eduardo F ^b   Martí Fàbregas, Joan ^a   Leta, Rubén G ^a   Baena, Manel ^b   Carreras, Francesc ^a   Pons Lladó, Guillem ^a   Baiget, Montserrat ^b   Martí Vilalta, Josep Lluis ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cryptogenic; Genetics; NKX2 5; Patent foramen ovale; Stroke

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EXON; FEMALE; GENDER; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NKX2 5 GENE; NUCLEOTIDE SEQUENCE; PATENT FORAMEN OVALE; PERIPHERAL LYMPHOCYTE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; STROKE; STROKE PATIENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; DNA; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EXONS; FEMALE; FORAMEN OVALE, PATENT; GENE FREQUENCY; HOMEODOMAIN PROTEINS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; SPAIN; STROKE; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 67650421514     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.04.004     Document Type: Article

References (42)

1. Connuck D., Sun J.P., Super D.M., Kirchner H.L., Fradley L.G., Harcar-Sevcik R.A., et al. Incidence of patent ductus arteriosus and patent foramen ovale in normal infants. Am J Cardiol 89 (2002) 244-247
2. Scammon R.E., and Norris E.H. On the time of the post-natal obliteration of the fetal blood-passages (foramen ovale, ductus arteriosus, ductus venosus). Anat Rec. 15 (1918) 165-180
3. Thompson T., and Evans W. Paradoxical embolism. Quart J Med 23 (1930) 135-150
4. Patten B.M. The closure of the foramen ovale. Am J Anat 48 (1931) 19-44
5. Hagen P.T., Scholz D.G., and Edwards W.D. Incidence and size of patent foramen ovale during the first 10 decades of life. Mayo Clin Proc 59 (1984) 17-20
6. Job F.P., Ringelstein E.B., Grafen Y., Flachskampf F.A., Doherty C., Stochmanns A., et al. Comparison of transcranial contrast Doppler sonography and transesophageal contrast echocardiography for the detection of patent foramen ovale in young stroke patients. Am J Cardiol 74 (1994) 381-384
7. Serena J., Segura T., Pérez-Ayuso M.J., Bassaganyas J., Molins A., and Dávalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 29 (1998) 1322-1328
8. Belvis R., Leta R.G., Martinez-Domeno A., Planas F., Marti-Fabregas J., Carreras F., et al. Electrocardiographic findings in patients with cryptogenic ischemic stroke and patent foramen ovale. J Electrocardiol 40 (2007) 168-171
9. Belvis R., Leta R.G., Marti-Fabregas J., Cocho D., Carreras F., Pons-Llado G., et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimag 16 (2006) 133-138
10. Belvís R., Martí-Fàbregas J., Cocho D., and Martí-Vilalta J.L. Secondary stroke prevention in patients with cryptogenic stroke and patent foramen ovale. Vasc Dis Prevent 3 (2006) 129-141
11. Conheim J. Pathologie. In: Thrombose und Embolie: Vorslesung über allgemeine. Berlin, Germany: Hirschwald; 1877:134.
12. Berthet K., Lavergne T., Cohen A., Guize L., Bousser M.G., Le Heuzey J.Y., et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 31 (2000) 398-403
13. Cabanes L., Mas J.L., Cohen A., Amarenco P., Cabanes P.A., Oubary P., et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24 (1993) 1865-1873
14. Thomas P.S., Kasahara H., Edmonson A.M., Izumo S., Yacoub M.H., Barton P.J., et al. Elevated expression of Nkx-2.5 in developing myocardial conduction cells. Anat Rec 263 (2001) 307-313
15. Lints T.J., Parsons L.M., Hartley L., Lyons I., and Harvey R.P. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119 (1993) 419-431
16. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281 (1998) 108-111
17. Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104 (1999) 1567-1573
18. Hosoda T., Komuro I., Shiojima I., Hiroi Y., Harada M., Murakawa Y., et al. Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient. Jpn Circ J 63 (1999) 425-426
19. Goldmuntz E., Geiger E., and Benson D.W. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation 104 (2001) 2565-2568
20. Ikeda Y., Hiroi Y., Hosoda T., Utsunomiya T., Matsuo S., Ito T., et al. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circ J 66 (2002) 561-563
21. Gutierrez-Roelens I., Sluysmans T., Gewillig M., Devriendt K., and Vikkuta M. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene. Hum Mutat 20 (2002) 75-76
22. Watanabe Y., Benson D.W., Yano S., Akagi T., Yoshino M., and Murria J.C. Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. J Med Genet 39 (2002) 807-811
23. McElhinney, Geiger E., Blinder J., Benson D.W., and Goldmutntz E. NKX2.5 mutations in patients with congenital heart diseases. J Am Coll Cardiol 42 (2003) 1650-1655
24. Kasahara H., and Benson D.W. Biochemical analyses of eight NKX2-5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc Res 64 (2004) 40-51
25. Reamon-Buettner S.M., Hecker H., Spanel-Borowski K., Craatz S., Kuenzel E., and Borlak J. Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations. Am J Pathol 164 (2004) 2117-2125
26. Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 135 (2005) 47-52
27. Sarkozy A., Conti E., Neri C., D'Agostino R., Digilio M.C., Esposito G., et al. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 42 (2005) e16
28. Biben C., Weber R., Kesteven S., Stanley E., McDonald L., Elliot D.A., et al. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87 (2000) 888-895
29. Kirk E.P., Hyun C., Thomson P.C., Lai D., Castro M.L., Biben C., et al. Quantitative trait loci modifying cardiac atrial septal morphology and risk of patent foramen ovale in the mouse. Circ Res 98 (2006) 651-658
30. Tanaka M., Berul C.I., Ishii M., Jay P.Y., Wakimoto H., Douglas P., et al. A mouse model of congenital heart disease: cardiac arrhythmias and atrial septal defect caused by haploinsufficiency of the cardiac transcription factor Csx/Nkx2.5. Cold Spring Harb Symp Quant Biol 67 (2002) 317-325
31. Firouzi M., Ramanna H., Kok B., Koeleman B.P.C., Doevendans P.A., Groenewegen A., et al. Association of human connexin 40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 95 (2004) 29-33
32. Wetzel U., Boldt A., Lauschke J., Weigl J., Schirdewahn P., Dorszewsli, et al. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart 91 (2005) 166-170
33. Kasahara H., Ueyama T., Wakimoto H., Liu M.K., Maguire C.T., Converso K.L., et al. Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J Mol Cell Cardiol 35 (2003) 243-256
34. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke: definition for use in multicenter clinical trial. Stroke 24 (1993) 35-41
35. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1216
36. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., et al. GATA4 mutations cause human congenital heart defects and reveal interaction with TBX5. Nature 424 (2003) 443-447
37. Bruneau B.G., Nemer G., Schmitt J.P., Charron F., Robitaille L., Caron S., et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106 (2001) 709-721
38. Akçaboy M.I., Cengiz F.B., Inceoǧlu B., Uçar T., Atalay S., Tutar E., et al. The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart anomalies: mutation or polymorphism?. Pediatr Cardiol 29 (2008) 126-129
39. Liu H.X., Cartegni L., Zhang M.Q., and Krainer A.R. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27 (2001) 55-58
40. Lorson C.L., Hahnen E., Androphy E.J., and Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96 (1999) 6307-6311
41. Elliott D.A., Kirk E.P., Yeoh T., Chandar S., McKenzie F., Taylor P., et al. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplasic left heart syndrome. J Am Coll Cardiol 41 (2003) 2072-2076
42. Posch M.G., Perrot A., Schmitt K., Mittelhaus S., Esenwein E.M., Stiller B., et al. Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A 146A (2008) 251-253